Omega Healthcare Investors, Inc.

OHI Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.

Revenue
+9.30%
EPS
−52.4%
Free cash flow
−12.1%
Total debt
−19.5%

Quarter to September 2026, against a year earlier

48.21 0.22 +0.46%
Market cap
$14.5B
P/E
19.2×
Fwd P/E
19.0×
Dividend yield
5.60%
F-score
6/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Omega Healthcare Investors, Inc. (OHI) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 11 added · 12 removed · 40 modified
P2I1A: no material changes, the filing says
8-K Nov 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 5, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 1, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 30, 2026 P1I2: 29 added · 2 removed · 43 modified
P2I1A: no material changes, the filing says
8-K Jul 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 5, 2026 5.07 Submission of matters to a vote of security holders; 8.01 Other events
8-K May 19, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 22 added · 8 removed · 45 modified
1A: 19 added · 5 removed · 28 modified
7: 15 added · 16 removed · 37 modified
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 1, 2026 5.02 Departure or appointment of directors or officers
8-K Nov 3, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 15, 2025 1.02 Termination of a material definitive agreement
8-K Sep 30, 2025 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 15, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Jul 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 1, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.